Jena, Germany

Udo Grafe

This inventor holds 1 USPTO granted patent. Top assignee: Veb Jenapharm. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Udo Grafe: Innovator in Antibiotic Production

Introduction

Udo Grafe is a notable inventor based in Jena, Germany. He has made significant contributions to the field of antibiotic production, particularly through his innovative processes. His work has led to advancements in the fermentation techniques used to produce effective antibiotics.

Latest Patents

Udo Grafe holds a patent for a process for the production of nourseothricine and its adsorbate. This process involves the fermentative production of the antibiotic nourseothricin, utilizing various carbohydrate sources, nitrogen sources, and mineral salts. The method emphasizes the importance of regulating acidity conditions and phosphate substance exchange to cultivate high concentrations of the antibiotic in the culture solution. The recovery of the active substance can be achieved through chromatographic techniques or by adding a physiologically compatible adsorbent, resulting in a mycelium-containing nourseothricin-adsorbate.

Career Highlights

Grafe's career is marked by his work at Veb Jenapharm, where he has been instrumental in developing innovative antibiotic production methods. His expertise in fermentation processes has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Udo Grafe has collaborated with notable colleagues, including Ernst-Joachim Bormann and Peter-Jurger Muller. These partnerships have contributed to the advancement of research and development in antibiotic production.

Conclusion

Udo Grafe's contributions to the field of antibiotic production through his innovative processes have made a lasting impact. His work continues to influence the pharmaceutical industry and the development of effective antibiotics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…